282 related articles for article (PubMed ID: 28468736)
1. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study.
Drago F; Ciccarese G; Cogorno L; Calvi C; Marsano LA; Parodi A
Eur J Dermatol; 2017 Aug; 27(4):382-385. PubMed ID: 28468736
[TBL] [Abstract][Full Text] [Related]
2. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide for skin cancer chemoprevention.
Damian DL
Australas J Dermatol; 2017 Aug; 58(3):174-180. PubMed ID: 28321860
[TBL] [Abstract][Full Text] [Related]
5. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
6. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
7. ACP Journal Club. In high-risk patients, oral nicotinamide reduced number of new nonmelanoma skin cancers during treatment.
Hajdenberg J
Ann Intern Med; 2016 Feb; 164(4):JC18. PubMed ID: 26882303
[No Abstract] [Full Text] [Related]
8. Skin cancer: Nicotinamide reduces new skin cancer risk.
Sidaway P
Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26525684
[No Abstract] [Full Text] [Related]
9. Nicotinamide found to reduce the rate of nonmelanoma skin cancers in high-risk patients.
Barton MK
CA Cancer J Clin; 2016; 66(2):91-2. PubMed ID: 26754863
[No Abstract] [Full Text] [Related]
10. Actinic keratosis-related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case-control study.
Jiyad Z; O'Rourke P; Soyer HP; Green AC
Br J Dermatol; 2017 Apr; 176(4):965-970. PubMed ID: 27584866
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide for Skin-Cancer Chemoprevention.
Drago F; Ciccarese G; Parodi A
N Engl J Med; 2016 Feb; 374(8):789-90. PubMed ID: 26933858
[No Abstract] [Full Text] [Related]
12. Nicotinamide for Skin-Cancer Chemoprevention.
Zhao Y
N Engl J Med; 2016 Feb; 374(8):789. PubMed ID: 26933857
[No Abstract] [Full Text] [Related]
13. Nicotinamide for Skin-Cancer Chemoprevention.
Chen AC; Martin AJ; Damian DL
N Engl J Med; 2016 Feb; 374(8):790. PubMed ID: 26933856
[No Abstract] [Full Text] [Related]
14. New and current preventive treatment options in actinic keratosis.
Arenberger P; Arenbergerova M
J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():13-17. PubMed ID: 28805940
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide for prevention of nonmelanoma skin cancers: a change in practice?
Nestor L; Clowry J; Molloy K; Connolly M; Salim A; Tobin AM
Clin Exp Dermatol; 2017 Dec; 42(8):945-946. PubMed ID: 29044731
[No Abstract] [Full Text] [Related]
16. Oral Nicotinamide for Actinic Keratosis Prevention in Kidney Transplant Recipients: A Pilot Double-Blind, Randomized, Placebo-Controlled Trial.
Zhang H; George-Washburn EA; Hashemi KB; Cho E; Walker J; Weinstock MA; Bostom A; Robinson-Bostom L; Gohh R
Transplant Proc; 2023 Nov; 55(9):2079-2084. PubMed ID: 37838527
[TBL] [Abstract][Full Text] [Related]
17. Actinic Keratosis in Solid Organ Transplant Recipients: A Medical Literature Review.
Morelló Vicente A; Oteiza Rius I; Aguado Gil L
Actas Dermosifiliogr; 2024 Apr; 115(4):368-373. PubMed ID: 37925069
[TBL] [Abstract][Full Text] [Related]
18. Risk of skin cancer development in 672 patients affected by actinic keratosis.
Dika E; Fanti PA; Misciali C; Vaccari S; Crisman G; Barisani A; Baraldi C; Ribero S; Patrizi A
G Ital Dermatol Venereol; 2016 Dec; 151(6):628-633. PubMed ID: 26381460
[TBL] [Abstract][Full Text] [Related]
19. [Translated article] Actinic Keratosis in Solid Organ Transplant Recipients: A Medical Literature Review.
Morelló Vicente A; Oteiza Rius I; Aguado Gil L
Actas Dermosifiliogr; 2024 Apr; 115(4):T368-T373. PubMed ID: 38336247
[TBL] [Abstract][Full Text] [Related]
20. Local interventions for actinic keratosis in organ transplant recipients: a systematic review.
Heppt MV; Steeb T; Niesert AC; Zacher M; Leiter U; Garbe C; Berking C
Br J Dermatol; 2019 Jan; 180(1):43-50. PubMed ID: 30188570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
